efflux pumps are a category of AR determinants characterized by the tightly regulation of their 23 expression. Their contribution to acquired AR relies in their overexpression. Herein we 24 analyzed potential inducers of the expression of the chromosomally-encoded Pseudomonas 25 aeruginosa clinically-relevant efflux pumps, MexCD-OprJ and MexAB-OprM. For this 26 purpose, we developed a set of luxCDABE-based P. aeruginosa biosensor strains, which allows 27 the high-throughput analysis of compounds able of modifying the expression of these efflux 28 pumps. Using these strains, we analyzed a set of 240 compounds present in Biolog Phenotype 29
Microarrays. Several inducers of the expression of the genes that encode these efflux pumps 30
were found. The study focused in dequalinium chloride, procaine and atropine, compounds that 31 can be found in clinical settings. Using real-time PCR, we confirmed that these compounds 32 indeed induce the expression of mexCD-oprJ. In addition, P. aeruginosa presents lower 33 susceptibility to ciprofloxacin (a MexCD-OprJ substrate) when dequalinium chloride, procaine 34 or atropine are present. This work emphasizes the need of studying compounds that can trigger 35 transient AR during antibiotic treatment, a phenotype difficult to discover using classical 36 susceptibility tests. 37 38 INTRODUCTION 39 transient reduction in the susceptibility to antibiotics (28, 29) , a situation that is not easily 66 detected using common susceptibility methods (8, 29) , is a relevant topic. 67
In the current work, we addressed this issue by analyzing two relevant P. aeruginosa efflux 68 pumps that present different levels of basal expression, Previous studies have shown that mexAB-oprM expression is induced by oxidative stress (30), 70 triclosan and pentachlorophenol (31), while envelope stress, benzalkonium chloride, 71 chlorhexidine, tetraphenylphosphonium chloride, ethidium bromide, rhodamine 6G or 72 antimicrobial human peptides are inducers of mexCD-oprJ expression. By the 73 screening of a set of compounds present in Biolog Phenotype Microarrays, an approach that has 74 been previously validated as a useful strategy to discover novel inducers of the expression of the 75 genes that encode efflux pumps (36, 37), we have detected different molecules that induce the 76 expression of mexAB-oprM and mexCD-oprJ in P. aeruginosa. For further analysis, we focused 77 on molecules that this bacterial pathogen can potentially encounter when producing an 78 infection, as procaine, atropine or dequalinium chloride. This work highlights the potential risk 79 associated to the utilization of these compounds in clinical settings, as inducers of transient AR 80 in P. aeruginosa, when antibiotic treatments are applied. 81
MATERIALS AND METHODS 82

Bacterial strains, plasmids and culture conditions 83
Bacterial strains and plasmids used in this work are listed in Table 1 . Unless otherwise stated, 84 all strains were grown in Lysogenic Broth, Lennox (LB) (Pronadisa) at 37ºC and 250 rpm. 85
Escherichia coli strains carrying the mini-CTX-lux (Tc R ) or pGEM-T Easy Vector derived 86 plasmids were grown in LB medium with 10 µg/ml of tetracycline or 100 µg/ml of ampicillin, 87 respectively. 88
Construction of mini-CTX::PmexAB-lux and mini-CTX::PmexCD-lux reporter plasmids 89
To obtain the mini-CTX::PmexAB-lux and mini-CTX::PmexCD-lux reporter plasmids, a mini-90 CTX-lux (Tc R ) plasmid (38) was digested with EcoRI and BamHI (New England BioLabs). The 91 strains. For that purpose, these biosensor strains were grown in from the PM11C to PM20B 118 bacterial chemical susceptibility plates of Phenotype MicroArrays™ (BIOLOG) and both 119 absorbance and bioluminescence emitted were monitored along time. 100 μl of LB medium 120 were added to each well of 96-well plates, and the plates were incubated during 2 hours with 121 agitation at room temperature to dissolve the lyophilized compounds. A volume of 10 μl of cell 122 culture was inoculated in each well to a final OD 600nm of 0.01. Bacteria were grown at 37ºC for 123 20 hours, and OD 600nm and luminescence was measured every 10 minutes using a Tecan Infinite 124 200 plate reader (Tecan). 125
Normalization of the results 126
The ratio luminescence emitted/OD 600nm was calculated in those wells in which the growth rate 127 was not impaired, and the resulting values were represented in a graphic against time. The area 128 under the curve for each graphic was calculated using the GraphPad Prism software, giving rise 129 to a collection of numeric values which represent the luxCDABE expression in PAO1 CTX-130 lux::PmexCD, PAO1 CTX-lux::PmexAB and PAO1 CTX-lux strains when growing in each 131 specific condition. Afterwards, each numeric value obtained in each tested strain (PAO1 CTX-132 lux::PmexAB and PAO1 CTX-lux::PmexCD) was normalized by dividing the value 133 corresponding to the same condition for the control strain (PAO1 CTX-lux). 134
The distribution of every normalized luminescence value obtained from each biosensor strain 135 was represented in a box plot in order to determine the threshold from which one value will be 136 consider as indicator of significant induction or repression. This threshold was determined as 137 previously described (37), using the formula Q 3 + 1.5 X IQR for the induction or Q 1 -1.5 X 138 IQR for the repression, being Q 3 the upper quartile, Q 1 the lower quartile and IQR the 139 interquartile range for each data set. 140
Analysis of potential effectors in the expression of mexCD-oprJ and in the susceptibility of 141
P. aeruginosa to ciprofloxacin 142
The growth of P. aeruginosa was analyzed by measuring the absorbance OD 600nm of bacterial 143 cultures. 10 μl of diluted overnight bacterial cultures were added to 140 μl of LB medium with 144 or without 0.25 μg/ml ciprofloxacin, atropine (ranging 1 to 8 mg/ml), procaine (ranging 1 to 8 145 mg/ml) or dequalinium chloride (ranging 1 to 500 µg/ml) in Flat white 96-well plates with 146 optical bottom (Thermo Scientific Nunc), at a final OD 600nm of 0.01. To determine the effect of 147 these potential effectors, the luminescence of either the PAO1 CTX-lux::PmexCD or the PAO1 148 CTX-lux reporter strains was measured in presence and in absence of atropine, procaine or 149 dequalinium chloride. Measures were taken every 10 minutes during 20 or 42 hours in a plate 150 reader (Tecan Infinite 200) at 37ºC. The average of three biological replicates for each strain 151 and condition was used to estimate the values of absorbance and luminescence. 152
RNA preparation and real-time PCR 153
An overnight culture of P. aeruginosa PAO1 was used to inoculate Erlenmeyer flasks with 20 154 ml of LB broth to a final OD 600nm of 0.01. The flasks were incubated at 37ºC and 250 rpm until 155 exponential phase of growth (OD 600nm = 0.6) was reached. Then, the optimal concentrations of 156 each tested compound (10 μg/ml of dequalinium chloride, 2 mg/ml of procaine and 2 mg/ml of 157 atropine) were added to each flask and cultures were incubated for 90 minutes with shaking, as 158 previously described in (37), to perform the induction assay; bacterial cultures without any 159 compound or with ethanol in the case of dequalinium chloride, the solvent of this compound, 160 were used as negative controls, and a mexCD-oprJ overexpressing strain (nfxB*) (Table 1) , 161 grown in the absence of inducer, was used as a control of mexCD-oprJ overexpression. 162
Afterwards, 10 ml of each culture were pelleted by centrifugation at 7000 rpm and 4ºC for 20 163
minutes. 164
The RNA extraction from the collected cells was performed as previously described in (40). 165
After a DNase I (Qiagen) treatment, a second treatment using DNase Turbo DNA-free 166 (Ambion) was performed, and the presence of DNA contamination was checked by PCR using 167 primers rpsL_Fw and rpsL_Rv (Table 2) . By using the High-Capacity cDNA reverse 168 transcription kit (Applied Biosystems), cDNA was obtained from 10 μg of RNA. 169
Real-time PCR was carried out with Power SYBR green PCR master mix (Applied Biosystems) 170
in an ABI Prism 7300 real-time system (Applied Biosystems). 50 ng of cDNA were used in 171 each reaction, except for the wells with no template that were used as negative controls. A first 172 denaturation step at 95°C for 10 minutes was followed by 40 cycles at 95°C for 15 seconds and 173 60°C for 1 minute for amplification and quantification. Primers that amplify specific fragments 174 of mexC were used at 400 nM (Table 2) . Primers rplU_RTPCR_Fw and rplU_RTPCR_Rv were 175 used to amplify the housekeeping gene rplU. All the primers used were designed with Primer3 176 Input software; their specificity was tested by BLAST alignment against P. aeruginosa genome 177 from Pseudomonas Genome Database (http://www.pseudomonas.com/) and their efficiency was 178 analyzed by Real-time PCR using serial dilutions of cDNA. Differences in the relative amounts 179 of mRNA were determined according to the 2 -ΔΔCT method (41, 42) . In all cases, the values of 180 relative mRNA expression were determined as the average of three independent biological 181 replicates each one containing three technical replicates. 182
Determination of the susceptibility to antibiotics of P. aeruginosa in presence of inducers 183 of mexCD-oprJ expression 184
Ciprofloxacin, fosfomycin, tobramycin and ceftazidime susceptibility assays were carried out 185 using MIC-test strips (Liofilchem®) in Mueller Hinton Agar (Pronadisa) containing either 10 186 μg/ml of dequalinium chloride, 2 mg/ml of procaine, 2 mg/ml of atropine or without any 187 inducer, following supplier's instructions. Overnight bacterial cultures were normalized to an 188 OD 600nm of 2.5 and a 1:1000 dilution of each culture was inoculated in the test plates and 189 incubated at 37ºC. In the case of inducers leading to small MIC changes (< 2 times), growth 190 curves were recorded using a Tecan Infinite 200 plate reader, as previously mentioned. 191
RESULTS AND DISCUSSION 192
Construction and validation of reporter strains 193
In order to identify potential inducers of the expression of either mexCD-oprJ or mexAB-oprM, 194 which could trigger P. aeruginosa non-heritable resistance to antibiotics, a set of biosensor 195 strains of P. aeruginosa PAO1 containing the mexCD-oprJ or the mexAB-oprM promoter 196 regions controlling the luxCDABE operon (PAO1 CTX-lux::PmexCD and PAO1 CTX-197 lux::PmexAB respectively) and the control strain PAO1 CTX-lux, were developed as described 198
in Materials and Methods. The proper functioning of the developed reporter strains was 199 analyzed by measuring luminescence and OD 600nm of each strain in the presence of known 200 inducers, benzalkonium chloride at 10 µg/ml for mexCD-oprJ (34) and H 2 O 2 at 0.136 µg/ml for 201 mexAB-oprM (30). The luminescence values were normalized with respect to those obtained 202 from the control strain PAO1 CTX-lux, as described in Materials and Methods. The presence of 203 the known inducers produced an increase in luminescence emitted by the corresponding 204 biosensor strain of 1.92-fold in the case of benzalkonium chloride, and 1.94-fold in the case of 205 H 2 O 2 in comparison to that produced in LB medium without inducers. These results validate the 206 capability of these biosensor strains to detect mexAB-oprM and mexCD-oprJ inducers. 207
Screening for inducers of mexCD-oprJ and mexAB-oprM expression using Biolog 208
Phenotype Microarrays 209
The capability of 240 compounds, present in the PM11C to PM20B bacterial chemical 210 susceptibility arrays of Phenotype MicroArrays™ (BIOLOG), for inducing the expression of 211 either mexCD-oprJ or mexAB-oprM was tested. Among these compounds, there were 212 antibiotics, heavy metals, antiseptics, fungicides, food preservatives, chelating agents, oxidative 213 stress compounds, amino acids, synthetic organic compounds and different drugs for human and 214 veterinary use. Four different concentrations of each compound are present in each commercial 215 microarray plate. However, only those in which the growth of the biosensor strain was not 216 severely impaired were considered for the analysis. 217
Luminescence emitted and OD 600nm were recorded for each biosensor strain (PAO1 CTX-218 lux::PmexCD and PAO1 CTX-lux::PmexAB) and these values were normalized with those 219 obtained from the control strain (PAO1 CTX-lux) as described in Materials and Methods. The 220 distribution of normalized values for each promoter was represented in a box plot ( Figure 1 ) and 221 an induction threshold level was calculated for each reporter strain as described in Materials and 222
Methods. These threshold values were 1.73 and 1.53 for mexCD-oprJ and mexAB-oprM 223 promoter, respectively. Those compounds that produced a fold change in luminescence that 224 exceeded the calculated threshold were considered as potential inducers and are shown in Table  225 3. For mexCD-oprJ, 20 putative inducers were detected, while 10 compounds were found to 226 increase luminescence above the threshold in the case of the mexAB-oprM biosensor strain. 227
Among the latter, we found some compounds already known to be inducers of mexAB-oprM 228 expression, which reinforce the robustness of our experimental approach. These include, 229 pentachlorophenol, which was previously described to induce mexAB-oprM expression (31), or 230 compounds that may lead to oxidative stress, which is a known inducer condition (30), such as 231 flavins or their derivatives (acriflavine, proflavine or 9-aminoacridine) (43) or iodoacetic acid. 232
Novel inducers of mexAB-oprM expression detected during the analysis include antibiotics as 233 amikacin and azlocillin (14), sanguinarine, which is a plant-derived compound, ethionamide, 234 which is used as an antibiotic for treating multidrug resistant Mycobacterium tuberculosis (44) 235 and sodium cyanate, a neurotoxic compound implicated in neurodegenerative disorders in 236 populations subsisting on the cyanogenic plant cassava (45) (see Table 3 ). 237
Concerning MexCD-OprJ, an efflux pump known to be induced by membrane-damaging agents 238 (32, 33), novel putative inducers of its expression were found. Among them, disinfectants 239 (benthezonium chloride, dequalinium chloride, domiphen bromide, alexidine and 240 cetylpyridinium chloride), the chelating agent 2, 2'-dipyridyl, sodium cyanate, 241 methyltrioctylammonium chloride, iodonitro tetrazolium violet, flavin derivatives (acriflavine, 242 proflavine and 9-aminoacridine), the anesthetic agent procaine, the antidepressant drug 243 amitriptyline, the antihistaminic agent orphenadrine, the β-blocker propranolol, the fungicide 244 dodine and some plant-derived compounds (atropine, harmane and sanguinarine), were 245 identified (see Table 3 ). 246
Regarding plant-derived compounds, it is worth mentioning that some of them, as the 247 flavonoids, play important physiological functions in plants as well as in plant-bacteria 248 interactions (46), and it is known that the flavonoid-responsive efflux pump MexAB-OprM of 249
Pseudomonas syringae is required for the efficient bacterial colonization of tomato plants (47). 250
Since P. aeruginosa is widely distributed in different natural habitats, including plants (48), it 251 seems possible that these efflux pumps could have a role in colonizing such habitats (25, 26) . 252
In addition to the detected inducers of mexCD-oprJ and mexAB-oprM expression, some 253 compounds (Table 4) were found to reduce the expression of these efflux pumps below the 254 lower threshold (1.1 for mexCD-oprJ and 0.7 for mexAB-oprM) for each of both promoters 255 calculated as described in Materials and Methods. For mexCD-oprJ, those compounds were the 256 antibiotics chloramphenicol, spectinomycin and spiramycin, and the plant derived compounds 257 nordihydroguaiaretic acid and gallic acid (see Table 4 ). For mexAB-oprM, there were antibiotics 258 such as hygromycin and josamycin, chromium chloride, glycine hydroxamate and protamine 259 sulfate (see Table 4 ). However, these compounds did not seem to be strong inhibitors, since the 260 normalized luminescence values measured in presence of them were close to those of the 261 threshold values and were not further studied. 262
Among the potential inducers, dequalinium chloride, procaine and atropine, which seemed to 263 induce the expression of mexCD-oprJ, were chosen for a deeper analysis because they are used 264 in human therapy and hence P. aeruginosa can grow in their presence when causing infections. 265
Inducers of expression of mexCD-oprJ with relevance in clinical settings 266
Dequalinium chloride is used as a disinfectant (49) and presents structural similarities to the 267 known inducers benzalkonium chloride and chlorhexidine (34), which promote the mexCD-oprJ 268 expression through the induction of an envelope-stress condition (32, 33). Further, several 269 compounds found as inducers in the analysis are similar to them in structure and/or biological 270 activity (benthezonium chloride, cetylpyridinium chloride, domiphen bromide or alexidine) and 271 are also used in clinical practice. This finding supports the potential relationship between 272 antibiotics and disinfectants resistance, as well as the possible induction of AR by disinfectants 273 of common use. In particular, the induction of mexCD-oprJ by dequalinium chloride could have 274 clinical relevance, as this compound forms part of several antiseptic and disinfection procedures 275 (50) and its use has been considered for the treatment for promyelocytic leukemia (51-54). 276
Procaine is used as a local anesthetic agent (55) in some minor surgeries or in burn injuries, 277 tissues that P. aeruginosa frequently colonize (56). Moreover, it has been studied for the 278 treatment of HIV patients (phase 2 clinical trial) (57). Therefore, the induction of mexCD-oprJ 279 by procaine should be taken into consideration in these patients since they are very susceptible 280 to P. aeruginosa infections (58). Finally, atropine is considered as an essential drug for 281 preoperative medication and sedation by the World Health Organization (44), so it may have an 282 effect on P. aeruginosa susceptibility to antibiotics when this microorganism infects surgical 283
patients. 284
Since concentrations of each compound in the Biolog plates are unknown, the mexCD-oprJ 285 reporter strain was grown during 20 hours in a range of concentrations in order to select one at 286 which an increase in luminescence is observed but bacterial growth is not compromised. These 287 concentrations are 10 µg/ml for dequalinium chloride, 2 mg/ml for procaine and 2 mg/ml for 288 atropine, and were the concentrations used for further studies. Luminescence measurements in 289 the presence of inducers at these optimal concentrations were recorded and normalized as 290 previously described. In all cases, the presence of the tested compounds increased the 291 luminescence produced by the biosensor strain (Figure 2) , further supporting they induce the 292 expression of mexCD-oprJ. 293
Dequalinium chloride, procaine and atropine induce mexCD-oprJ expression and transient 294 antibiotic resistance 295
In order to further confirm the inducing capacity of the compounds found in the screening, the 296 expression level of mexCD-oprJ was quantified by real-time PCR in the wild type P. 297 aeruginosa PAO1, grown in the presence or in the absence of the cognate inducer compounds. 298
The strain overexpressing mexCD-oprJ (nfxB*) ( Table 1) was used as efflux pump-299 overexpressing control strain. The expression of mexCD-oprJ increased by 54-fold in the 300 presence of dequalinium chloride, 25-fold in the presence of procaine and 16-fold in the 301 presence of atropine (Figure 3) . These results confirm that the expression of mexCD-oprJ is 302 induced by the compounds selected from the Biolog screening. 303
The P. aeruginosa PAO1 MIC of ciprofloxacin, one of the MexCD-OprJ substrates, was 304 analyzed in the presence and in the absence of the aforementioned inducers in order to 305 determine the effect of such induction on the susceptibility of P. aeruginosa to this antibiotic. A 306 strain that overexpresses mexCD-oprJ (nfxB*) and a mexD-defective mutant (nfxB*∆mexD) 307 (Table 1) were used as controls. MIC of ciprofloxacin was higher in the presence of the inducers 308 (Table 5) . Moreover, the presence of each inducer did not affect the MIC of ciprofloxacin for 309 nfxB* and nfxB*∆mexD, confirming that the observed phenotype was caused specifically by 310 mexCD-oprJ induction. In the case of atropine, which leads to lower increase of ciprofloxacin 311 MIC (2-fold), growth curves of PAO1 in presence of ciprofloxacin, with or without this inducer, 312
were also analyzed ( Figure 4) . The results confirm that atropine leads to a transient reduction of 313 P. aeruginosa ciprofloxacin susceptibility. 314
In order to further confirm the specific induction of mexCD-oprJ by these compounds, the MICs 315 of antibiotics which are not substrates of MexCD-OprJ (tobramycin, fosfomycin and 316 ceftazidime (8)), were also measured in presence and absence of the identified inducers. The 317
MICs of those antibiotics did not change in presence of the inducers. 318
Altogether, these results indicate that the three analyzed compounds are able to transiently 319 increase AR through the induction of the expression of the genes that encodes MexCD-OprJ. 320
Because of that, the temporal coincidence of any of these compounds with MexCD-OprJ 321 antibiotic substrates for treating patients may be a concern. 322 MexCD-OprJ efflux pump extrudes procaine 323
It has been found that in some occasions, inducers of the expression of efflux pumps are also 324 substrates of these AR determinants (22, 60-62). One example of this situation is the induction 325 of MexXY-OprM in P. aeruginosa by aminoglycosides, which are substrates of this efflux 326 pump (59). However, in other cases, as it happens in the case of S. maltophilia SmeVWX and 327
SmeYZ efflux pumps (37), some of their inducers are not substrates of these efflux pumps. 328
To address the capacity of MexCD-OprJ to extrude its described inducers, the growth of the 329 wild-type P. aeruginosa PAO1 and nfxB*∆mexD strain were compared in the presence of a 330 toxic concentration of each inducer (4 mg/ml of atropine, 4 mg/ml of procaine or 20 µg/ml of 331 dequalinium chloride). No relevant differences in growth were observed in presence of 332 dequalinium chloride or atropine in the MexD-deficient strain compared to the wild type. 333
However, growth of the MexD-deficient strain was reduced in the presence of procaine (Figure  334 5) indicating that this compound, besides being an inducer, might also be a substrate of the 335
MexCD-OprJ efflux pump. 336
CONCLUDING REMARKS 337
The combination of Biolog plates and luminescent biosensor strains has allowed us to describe 338 novel inducers of P. aeruginosa efflux pumps, some of which must be carefully taken into 339 consideration in the clinic field; in particular, when these compounds and antibiotics are 340 simultaneously applied. Moreover, this type of approaches, which has proven to be useful to 341 find new inducers of efflux pumps in P. aeruginosa, besides informing on the putative original 342 role of efflux pumps in non-clinical environments, may allow predicting potential conditions 343 triggering transient AR at clinical settings. 344 aeruginosa fitness in competition tests, but produces specific changes in bacterial regulatory 10 µg/ml of dequalinium chloride, 2 mg/ml of procaine, 2 mg/ml of atropine or without inducer. 580
Fold changes were calculated regarding the expression in P. aeruginosa PAO1 untreated. The 581 nfxB* strain grown in the absence of any inducer was used as a control of overexpression. Each 582 represented value is the average of three biological replicates. As shown, expression of mexCD-583 oprJ is induced by the three tested compounds. Statistically significant differences regarding 584 inducers. PAO1 wild-type strain (blue) and nfxB*∆mexD strain (red) were grown in LB as a 598 control (A) and in presence of 4 mg/ml of atropine (B), 4 mg/ml of procaine (C) or 20 µg/ml of 599 dequalinium chloride (D). As shown, the absence of MexCD-OprJ increases P. aeruginosa 600 susceptibility to procaine. Each OD 600nm represented value is the average of three biological 601 replicates. 602
